Octagos Health raised over $43 million in a Series B funding led by Morgan Stanley Expansion Capital to advance AI-Driven Cardiac Device Monitoring.

Jul 09, 2024•about 1 year ago

Amount Raised

$43 Million

Round Type

series b

HoustonHealthcare

Investors

Other Strategic InvestorsMucker CapitalMorgan Stanley Expansion Capital

Description

Octagos Health, an industry-leading provider of AI-driven cardiac device monitoring solutions, announced a successful equity raise of over $43 million in investment capital. This funding will accelerate Octagos Health's mission to use artificial intelligence to revolutionize cardiac care and provide comprehensive patient monitoring services.

Company Information

Company

Octagos Health

Location

Houston, Texas, United States

About

Octagos Health is a leading provider of cardiac monitoring solutions, dedicated to improving patient outcomes through advanced technology and comprehensive monitoring services. The company's AI-driven platform offers continuous monitoring and data analysis for patients with implantable cardiac devices, enabling healthcare providers to make informed decisions and deliver timely care. Octagos Health's solutions are designed to seamlessly integrate with electronic health records and provide customizable reporting features, making it an essential tool for modern healthcare institutions.

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech